Depressant effects of drugs used in myotonia therapy.
D000818:Animals; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects; D008012:Lidocaine / Q000031:analogs & derivatives / Q000494:pharmacology; D008801:Mexiletine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009222:Myotonia / Q000188:drug therapy*; D010672:Phenytoin / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011892:Rana catesbeiana; D016677:Tocainide
D007473:Ion Channels; D008801:Mexiletine; D016677:Tocainide; D010672:Phenytoin; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide